Back to Agenda
Digital Transformation Showcase
Session Chair(s)
Rodrigo Palacios, MBA
Senior Director, Technical Regulatory Policy, F. Hoffmann-La Roche Ltd., Switzerland
Ronnie Mundair
Regional Labelling Head - Canada and LATAM - Senior Director, Pfizer, United Kingdom
Do you hear the words ‘digital transformation’ or ‘digital future’ in our sector and think, well what does it apply to and what is the vision? When is it coming and what has been accomplished so far? And who will it impact and benefit? In the 1st of its kind Showcase at DIA – we want you to hear about some key area’s of progress and ‘touch and feel’ some of the future ‘to be’ digital tools and approaches that are being actively worked on; some of which will be at your ‘fingers tips’ soon. In this Digital Transformation session, you will hear a ‘pitch’ from each of our showcase speakers, whereafter you will be able to choose which station you would like to “touch and feel” more from and be able to move around each of the stations in short 10 min slots, so you can learn more about and ‘see’ what is being ‘digitally enabled’. Our overall objective for this type of unique session is that you will leave much more informed, excited and confident about digital advances for both the pharmaceutical sector and patients alike. Learning Objectives: Participants will have the opportunity to view enhanced use of information resources through featured real world demonstrations. Participants will learn how real-life use cases have leveraged structured, coded and connected content, to bring Labeling onto a new paradigm. Participants will have the opportunity to witness first hand, real time collaboration in support of reliance and regulatory convergence See how the unique global IDMP identifiers come to life in real time and leverage use cases such as pharmacovigilance and drug shortages worldwide. Participants will have the possibility to see demonstrations of added value in use of ePI as an active knowledge resource for citizens; patients and their support network.
Learning Objective : Discuss a Labeling process that is based on fully structured, coded product information and designed for quality, efficiency & interoperability. Illustrate FHIR ePI as key standard to exchange Labeling structured content amongst stakeholders. Outline advanced structured content-based health authority assessment. Evaluate potential for enhanced ePI usability with fully structured Labeling content.
Speaker(s)
Niklas Jaenich, PHD, RPH
Head of Global Labeling Operations and Digitization, Boehringer Ingelheim, Germany
Labelling Unleashed – The Power of Structured, Coded, and Connected Content
Michel De Ridder, MS
Partner, Deloitte, Belgium
Transformation of Regulatory Compliance Through Generative AI
Anne Moen, PHD, MSC, RN
Professor, Faculty of Medicine, Coordinator, Gravitate-Health , University of Oslo, Norway
Gravitate-Health: Demonstrating Value of Electronic Product Information (ePI) to Engage and Empower Patients
Dominique Lagrave, PHARMD
Chief Regulatory Officer, Accumulus Technologies, United States
Malin Fladvad, PHD, MSC
Portfolio Officer, Uppsala Monitoring Centre, Sweden
Unlocking the Potential of IDMP for Global Exchange of Medicinal Products Data
Rodrigo Palacios, MBA
Senior Director, Technical Regulatory Policy, F. Hoffmann-La Roche Ltd., Switzerland
Practical Showcase: A Closer Learning Opportunity
Have an account?
